Katie Burke

Katie Burke, CPA, currently serves as Senior Director of Finance and SEC Reporting at Q32 Bio Inc. since April 2024. Prior experience includes significant roles at Homology Medicines, Inc. as Senior Director of Finance & Accounting and Director of Accounting & Financial Reporting, and at Inotek Pharmaceuticals as Controller. At Cubist Pharmaceuticals, Katie was Manager of Technical Accounting, overseeing revenue recognition and SEC filings. Earlier experience includes consulting at Corporate Finance Group Inc., where duties encompassed technical accounting and interim financial management, as well as positions at Iron Mountain and PricewaterhouseCoopers in audit and accounting. Katie holds a Master’s in Accounting/MBA from D'Amore-McKim School of Business at Northeastern University and a Bachelor’s in Economics from Wheaton College Massachusetts.